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heets obtained. We undertook this study to test the hypoth-
esis that cyclic Row variations, occurring in patients after
coronary agioplasty, nay be attenuated or abolished by the
chimeric monaeioal antibody 00 Fab (7E3) to platelet
sulfate membrane glyeoprosein GFliblllla receptors .
14tcthod6
Study padems . The study group consisted of 27 patients
undergoing elective coronary angiuplasty of a single, dis-
crete lesion in a native artery. There were 20 men and 7
wtmten. They ranged in age between 40 and 77 years (mean
58 years) . Seventeen patients (63%, had unstable angina
.
Three patients previously had coronary artery bypass sur-
gery m 2.6 and I I years bctore the current angioplasty . One
patient bad a myocardial infarction I month before this
procedure, and six other patients had remote histories of
myocardial infarction. Selected clinical characteristics of the
patients are summmized in Table I .
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To* l. Auglog aphlc and Flow Data
Mann-Whitney tests. Values of p < 0.05 were considered
significant.
Results
Clinical ch ratlvritia, We monitored coronary flow in
27 patients after coronary angioplasty . During the 30-min
monitming period, we detected cyclic : flaw variations in five
patients (19%)
. Table I displays some dentogrsohie and
clinical variables for the 27 monitored patients. There were
so significant differences between the two groups . ]lo five
patients that developed cyclic flow variations was slightly
youngster on average darn thane patients without cyclic flows,
Also, 4 of 5 patients with cyclic flaws had unstable angina
and none of the 5 had) normal baseline electrocardiograms
(ECGs), whereas 13 patients without cyclic flows had Imsta-
We angina and g patients had normal ECUs . Activated
clotting times at the start of monitoring were the same for
both groups.
Angiprapbi data. All procedures were considered on,
gialaphically successful
at the lime that continuous flow
mooitmiag started
. For the entire group, the mean di'mcter
almonds before angicphety was 69 ± 14%. and it was 35 ±
15% Immediately afterward (Table 26 The group of patients
that developed cyclic flows was found nn later
quantitative
analysis not to have as favorable response to atgioplaaty
dilation, compared wish that without cyclic flaws (mean
diameter stenosis after dilation 47 ± 13% vs. 33 ± 15%. p <
0.05). By the end of the 30-min monitoring period, some
ANDERSONErAL
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elastic recoil effects were noted in both groups. but diameter
stenosis was still significantly greater in the group with cyclic
flows . Lesion length was greater in patients that developed
cyclic flow variations (18 .7 m 7.5 mm vs . 13.1 ± 5.7 mm .
p < 0.05) .
Platy velue{ydata. For the entire group . the average peak
velocity before angloplaety was 19 ± 12 coils, and it was
increased to 3D k 12 earls immediately after the procedures.
The increase a corvomy lbw velocity was the same for both
groups (fable 2). However. 30 min later, flow velocities had
decreased to lower values in those patients with cyclic flow
variations than in those without them (15 w 6 cm/s vs
. 23 t
9 cm/s, p < 0.05). The diastolic-to-systolic velocity ratio, a
measure of stenosir 6everb„ was significantly lower 30 min
after the procedures in those patients with cyclic flows.
Elimination or gdlc flow variations . fa four of the five
patients with cyclic flows, tae
monoclonal
antibody e7E3
Fab to the GPlIb/Illa receptor was administered intrave-
nously
. In all four eases, cycles were abolished and flow
stabilized within I min . In one of the five cases with cyclic
flows, redilaion of the lesion only wag performed, with
successful restoration of flow and no further cycles . Figure I
illustrates abolition of cyclic flows after 7E3 administration
.
Angiogratus at
30 min after treatment revealed what
appeared to be residual thrombus in three ot'the four patients
that received 7E3 . A! the discretion of the operator, intre-
corotmry urokinase 250.000 to 500.000 U was given to these
patients . There was no further change in coronary flow, and
Trill
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repeat angiogmphy revealed little or no c!hW In appeal ,
Met.
Ikmmlatk variables. After 7E) administration. platelet
counts decreased in two of the four treated patients (Fig.
2A). Platelet aggregation induced by 20 )unoNher of adta-
osine eriphesphate decreased sigtdfiancly by 2 h but then
recovered over the folluwig 4B
It
(Fig
. 2W. Bleeding cons,
plications were minimal and were not different from those at
other patients undergoing angioptasty. Only one patient
requited any transfusion .
MAW eamte. All Y7 patients had clinically suacssa)
procedures
. No patient required coronary hypass surgery,
and serial ECGs and cardiac enzyme delerndnatiana did not
reveal any myocardial infarctions .
Discinsloi
Coronary angioplasly causes immediate and dramatic
changes In coronary arterial walls
. Endothelia dendation
occurs and is often accompanied by deeper injury into the
media, thereby exposing Collagen, elastin, and smooth mus-
cle cells to circulating blood 117)
. Platelet accumulation VA
0
P 3n a ,A H` Ore,
Frsam L Top
. Platelet counts in four rstients after 7E) admilm-
tmlins. imam. Platelet aggregation induced by
21)
pnmyhikr of
adeaosine plmaptwte in fax patients alter 7E) admiuiagatiun .
the injured site is extensive and can precipitate total thram-
bodc occlusion of the vessel (11-20) . This proasee may be
the bmis for the phenomenon of abrupt vessel Closure niter
coronary mtpoplasty . There are parallels between the
phoektaeasel wag interactions of cotanasy mtgloplasty and
those that can occur spontaneously in arm coronary syn-
dromes (17)
. These paraleb include both the Initial Ana,
lion of occlusive thrtmhus m the loaned aurface of an
adbemsckrotk pha ate, which can occur with vostable an-
gina and acute myocardial infarclim, an wall as the phenam-
amon of mocdasion after successful themttbulysis fm acute
myoard l infarction (21,22).
Initial platelet adhesion to the isdmad oriental wall de-
pends en interaction between platelet aria membrane
receptors and adhesive glyeopeoteis in the well . Adhesion
begins a process of platelet activation, with ideate of the
Collkttma platelet storage granules. Released substances
include t iomboxane A s, semtaein
. edexosie diphosplmm .
platelet aetivatip factor. thrombin and possibly other prod-
acts. They mediate additional platelet activation, and several
of them came vasoeonauidim in the immdiate vicinity and
downstream km the site
. When platelet activation occurs,
GPtlblllla receptors chsag, frog low affinity to highaisty
binding states (23). Fi brinogen. van Wilebrad factor and
perhaps other glyooptokias can then bind and form bridging
cross-links between GP Ilb/ltla receptors an adjacent plate.
lets. The linking of these receptors conatiutes ibe final
common event aplatelet aggregation . Preventing this cross.
linking presents an npportwity to reduce or abolish platelet-
ihiated thrombi . sub as nay be involved in reocdusion
after tbrombolysis and abrupt reclosure with angioplasty .
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Platelet agiregidlen and cyclic flow variations . Coronary
artery cyclic flow variations can be attenuated or abolished
entirely by many agents that interfere with plate!--t function.
Altl
.ough blocking the effects of one or more of the previ-
ously mentioned platelet mediators is possible and can be
effective, others of these mediators are left unopposed to
stimulate platelet activation . For example . Ashton et al .
(8.24) demonstrated dual mediation of platelet aggregation
and cyclic flow variations by thromboxane A.- and serotonin
in an experimental animal model . A thromboxane A r
recep-
tor antagonist alone, or a serotonin receptor antagonist
alone . could abolish cyclic flows in many animals . However.
tome animals (approximately 259) required administration
of both thromboxane A . and serotonin receptor antagonists
together to abolish cycles . Similar results were. obtained by
Yen at al . (9) with combined thromboxanc A, synthetase
inhibition and thromhoxane A. receptor antagonism. be-
cause the final event in platelet aggregation is truss-linking at
surface membrane GP llbrpla receptor sites. it is reasonable
to suppose that a method of binding these receptors and
preventing cross-linking may be superior to single or multi-
ple antagonists, possibly avoiding the problem of aggrega-
tion induced by alternative mediators .
GP nb/IHa receptor anlagonhts
. Several agents can bind
to the llblllla receptor and affect platelet aggregation and
platelet-mediated events (25-28). One such agent is a mono-
clonal antibody to the receptor. the 7E3 antibody. Originally
a rune product. i t has now been modified into a chimeric
structure so that only die active site is nonhuman. Both
marine and chimeric forms are equipment in activity and
have been studied extensively in animal thrombosis models .
For example, Bates et al. (29) used electrical injury with
coronary slenosis to induce coronary artery thrombosis in a
chronic canine model . Dogs pretreated with placebo all
developed tltrombotic occlusion and died within 24 h . Dogs
pretreated with 0.9 mg/kg of 7E3 all had potent coronary
vessels at 24 h. and only tore died, 23 days later . Mickelson
a al. (30) used an acute electrical injury model of coronary
thrombosis and noted that lysis time (approximately 30 min)
was rot affected by the addition of 0 .8 mg/kg 7E3 to tissue
phisminogen activator (t-PA) .
However
. reocelusion rates
after thrombolysis were markedly reduced with the addition
of 7E3 . Using a different model of thrombin-injeclion with
coexistent high-grade coronary stamens, Yasoda a al. (31)
and Gold et al. (32) found that 783 added to t-PA could
accelerate Ihrombolysis in that model, as well as prevent or
delay later reocclusion. In a yet different model of coronary
thrombosis, a sccllo al coronary eversion graft with con-
strictor, Yasuda et al . (33) found that 0.8 mg/kg of 7E3 alone
was as good or better than t-PA alone in producing stable
Mediation without reocclusion
. However, the combination
of t-PA and 7E3 was even better. Finally, in an acute
angioplasty model. Bates et al . (34) treated dogs with either
placebo, 325 mg aspirin or 0
.8 mglkg of 7E3. Both abrupt
closure of the artery as well as accumulation of nonocciusive
thrombus were significantly less in dogs treated with 703
ANDERSON
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compared with those treated with aspirin or pkeehn . It may
be possible that some of the observed differences in results
in these studies, especially regarding lysis times, may be
model-dependent. reflecting the relative proportions of
platdct-rich and erythrocyte-rich thrombi but nevertheless
clearly showing that 7E3 is an effective antiplatclet agent .
Cyclic flow variations and 7E3 . The cyclic flow model of
coronary thrombus formation is well established (1-3). Cy-
clic variations in lbw also have been described in carotid
and femoral aaeries and appear to be a generalized platelet-
vessel wall response to arterial stenosis with endothelial
injury
(3S) . The importance of this model as a surrogate for
development of acute ischemic heart disease syndromes in
humans was recently emphasized by Ikeda et al. (36). The
pathophysimlogy of cycles of platelet accumulation, with
potential for progression to acute myocardial intbcetiau or
sudden lethal arrhythmia . closely resembles the sequence
that occurs in humans.
In dose-ranging studies with 7E3 in dogs and monkeys .
Coller et al . (37.38) found that blockade of approximately
50% of
GP llblllla receptors on platelet surfaces was suffi-
cient to abolish cyclic flows. and this result could be
achic cd with 70 doses of approximately 0.2 mg/kg, In
dose-ranging studies in humans, both Gold ct al
. (39) in 16
patients with unstable angina and Ellis et al . (40) in 23
patients undergoing elective coronary angioplasty found
dose-related effects on platelet aggregation, bleeding times
and the proportion of GP llblllla receptors blocked . In the
study by Ellis a al. (40). which also involved invasive
procedures such as our present study. serious bleeding did
not occur . Only ore of their patients required transfusion. at
did one of ours. In these two previous human studies using
7E3. coronary artery flow was not measured, so cyclic
variations in coronary blood flow could not be detected .
Cyclic floss variations after coronary angioptasty in hu-
mans. Patients undergoing coronary angioplasty are treated
usually with aspirin, nitrates, calcium channel antagonists
and heparin . These medications are given specifically to
interfere with coronary artery vasoreactivity and platelet
function . They have been found to be useful in treating
coronary vasospasm and preventing abrupt closure during
and after angioplasty procedures . Nevertheless, coronary
artery cyclic flow variations can be detected after coronary
angioplasty In some patients
. In a previous study (5), we
found that 23% (3 of 13) of the monitored patients had cyclic
alterations in coronary flow detected after coronary angio-
plasty
. This result is similar to the 19% (5 of 27) that we
found in the present study . All three patients detected
pr viously
. and four
of
the five patients detected in the
present study, had unstable angina . This clinical syndrome is
known to be associated with higher frequencies of fissured
coronary plaque and intracoronary thrombus 141 .42). Fun
thermorc, coronary angioplasty performed for unstable an-
gina is associated with increased risk of abrupt coronary
closure, presumably on the basis of platelet-initiated throm-
bus formation (43). Whether cyclic flow variations are a
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